Queensland researchers have identified a key cause of severe COVID-19, paving the way for a potential new treatment.
Unlike antiviral treatments, Mater Research biochemist Katharina Ronacher said the experimental medication would not attack SARS-CoV-2, the virus that causes COVID-19, but was designed instead to target the immune system.